CoChat

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease.

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

The biologic mechanisms involved in the pathogenesis of multiple myeloma (MM) bone disease are not completely understood. Recent evidence suggests that T cells may regulate bone resorption through the cross-talk between the critical osteoclastogenetic factor, receptor activator of nuclear factor-κB ligand (RANKL), and interferon γ (IFN-γ) that strongly suppresses osteoclastogenesis. Using a coculture transwell system we found that human myeloma cell lines (HMCLs) increased the expression and secretion of RANKL in activated T lymphocytes and similarly purified MM cells stimulated RANKL production in autologous T lymphocytes. In addition, either anti–interleukin 6 (anti–IL-6) or anti–IL-7 antibody inhibited HMCL-induced RANKL overexpression. Consistently, we demonstrated that HMCLs and fresh MM cells express IL-7 mRNA and secrete IL-7 in the presence of IL-6 and that bone marrow (BM) IL-7 levels were significantly higher in patients with MM. Moreover, we found that the release of IFN-γ by T lymphocytes was reduced in presence of both HMCLs and purified MM cells. Furthermore, in a stromal cell–free system, osteoclastogenesis was stimulated by conditioned medium of T cells cocultured with HMCLs and inhibited by recombinant human osteoprotegerin (OPG; 100 ng/mL to 1 μg/mL). Finally, RANKL mRNA was up-regulated in BM T lymphocytes of MM patients with severe osteolytic lesions, suggesting that T cells could be involved at least in part in MM-induced osteolysis through the RANKL overexpression.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2002-04-1121

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 3

  1. Altamirano, 2000, RANKL is expressed in malignant multiple myeloma cell lines [abstract]., Blood., 96, 360a
  2. Faust, 1999, Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors., J Cell Biochem., 72, 67, 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A · doi:10.1002/(sici)1097-4644(19990101)72:1<67::aid-jcb8>3.0.co;2-a
  3. Kotake, 2001, Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients., Arthritis Rheum., 44, 1003, 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-# · DOI · Paper page

Cited by

See all 270

Metadata

Authors
Giuliani, N., Colla, S., Sala, R., Moroni, M., Lazzaretti, M., La Monica, S., Bonomini, S., Hojden, M., Sammarelli, G., Barillè, S., Bataille, R., & Rizzoli, V.
Affiliations
  • University of Parma (IT)
  • From the Hematology Departments of Internal Medicine and Biomedical Science, Experimental Medicine, and Pathology, University of Parma, Parma, Italy; and INSERM U463, Insitut de Biologie, Nantes, France.
Venue
Blood
Published
2002-12-15
Volume
100
Issue
13
Pages
4615-4621
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2164174012
Cited by
270
References
40
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 10 · 2014: 16 · 2013: 18 · 2012: 11
FWCI
5.85
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
multiple myeloma, bone disease, RANKL, T cells, osteoclastogenesis, interferon-gamma, IL-7, interleukin-6, osteoprotegerin, myeloma cells, bone resorption, osteolytic lesions, bone marrow
MeSH terms
Aged, Bone Marrow Cells, Carrier Proteins, Female, Glycoproteins, Humans, Lymphocyte Activation, Male, Membrane Glycoproteins, Middle Aged, Multiple Myeloma, Neoplasm Proteins, Osteoclasts, Osteolysis, Recombinant Proteins, RNA, Messenger, RNA, Neoplasm, T-Lymphocytes, Interleukin-6, Interleukin-7, Gene Expression Regulation, Neoplastic, Culture Media, Conditioned, Stromal Cells, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. https://app.cochat.ai/papers/10.1182/blood-2002-04-1121
The paper
Giuliani, N., Colla, S., Sala, R., Moroni, M., Lazzaretti, M., La Monica, S., Bonomini, S., Hojden, M., Sammarelli, G., Barillè, S., Bataille, R., & Rizzoli, V. (2002). Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood. https://doi.org/10.1182/blood-2002-04-1121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.